Scalable Public Health Empowerment, Research, and Education Sites (SPHERES)
- Sponsor
- Oxford University Clinical Research Unit Indonesia
- Study ID
- NCT07126041
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Diabetes Mellitus
- Hepatitis B
- Hypertension
- Neonatal Mortality
- Pregnancy
- Tuberculosis
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Interventions
- Prescription for Action (SPHERES Model) — OTHERA system-level intervention consisting of: * a digital dashboard displaying local health services, outcome indicators, and operational data in a secure Public Health Data Theater; * structured monthly prescription guides targeting service improvements across three priority program areas; * monthly performance monitoring with district health leaders. The intervention is applied at the PHC level, all supported by digital capacity building, district-level deployment of implementation teams, and intersectoral secure health data exchange.
Study Details
SPHERES is a health service research trial in the Indonesian primary care system designed to improve health system performance using a structured data-driven action model. The intervention empowers district health leaders to make data-informed decisions that will enhance outcomes across maternal, child, infectious, and non-communicable disease programs.
Key Dates
- Start date
- Aug 14, 2025
- Status verified
- Aug 2025
- Primary completion
- Dec 31, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 1,750,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: SPHERES Intervention ArmParticipants (district populations) receive services improved by the SPHERES model, which includes structured prescription-for-action protocols targeting three priority domains (infectious disease, maternal \& child health, and non-communicable diseases).
- No Intervention: ControlStandard of care are expected at primary health centers before the SPHERES intervention is deployed
Primary Outcome Measure
Difference in neonatal mortality rate between intervention and control periods [ Time Frame: Baseline up to 16 months, with data collected monthly at each site (i.e. baseline, at the end of month 1, at the end of month 2, and so on until at the end of month 16) ]
Central Contacts
- Zamzam Noerzen Djaelani, MD, MBA+6281385680388
- Rina Agustina, Prof.+6281297484775
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Evaluation of Patients With Liver DiseaseRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Genetic Studies of Insulin and DiabetesRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Effects of Oncological Treatment During Pregnancy on Mother and ChildRecruiting · University Hospital, Gasthuisberg · Camden, New Jersey